To summarize, PDE5 inhibitors are associated with a lower risk of dementia in patients and have beneficial effects in experimental mouse models of AD, supporting the potential use of PDE5 inhibitors for the prevention of AD. The gene discussed is PDE5A; the disease is dementia.